William Y. Lee

Array ( [id] => 20083617 [patent_doc_number] => 20250213553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-03 [patent_title] => BUPRENORPHINE DOSING REGIMENS [patent_app_type] => utility [patent_app_number] => 19/085650 [patent_app_country] => US [patent_app_date] => 2025-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10496 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19085650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 20083617 [patent_doc_number] => 20250213553 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-03 [patent_title] => BUPRENORPHINE DOSING REGIMENS [patent_app_type] => utility [patent_app_number] => 19/085650 [patent_app_country] => US [patent_app_date] => 2025-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10496 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19085650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19815014 [patent_doc_number] => 20250073221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-06 [patent_title] => METHODS AND PRODUCTS FOR IMPROVING SPERM QUALITY [patent_app_type] => utility [patent_app_number] => 18/949880 [patent_app_country] => US [patent_app_date] => 2024-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20539 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18949880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19613025 [patent_doc_number] => 20240398705 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-05 [patent_title] => OPHTHALMIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/784718 [patent_app_country] => US [patent_app_date] => 2024-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49410 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18784718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19526514 [patent_doc_number] => 20240350416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING ENZALUTAMIDE [patent_app_type] => utility [patent_app_number] => 18/762066 [patent_app_country] => US [patent_app_date] => 2024-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3999 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18762066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19554844 [patent_doc_number] => 20240366636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => ORAL CANNABINOID PHARMACEUTICAL COMPOSITIONS AND METHODS OF TREATING INFLAMMATORY GASTROINTESTINAL DISORDERS [patent_app_type] => utility [patent_app_number] => 18/759282 [patent_app_country] => US [patent_app_date] => 2024-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26161 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18759282 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19526598 [patent_doc_number] => 20240350500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-10-24 [patent_title] => PLK1 INHIBITOR IN COMBINATION WITH ANTI-ANGIOGENICS FOR TREATING METASTATIC CANCER [patent_app_type] => utility [patent_app_number] => 18/751006 [patent_app_country] => US [patent_app_date] => 2024-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23528 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18751006 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19554726 [patent_doc_number] => 20240366518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-07 [patent_title] => COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF [patent_app_type] => utility [patent_app_number] => 18/735095 [patent_app_country] => US [patent_app_date] => 2024-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70656 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18735095 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19730096 [patent_doc_number] => 12208082 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2025-01-28 [patent_title] => Method of treating middle east respiratory syndrome (MERS) [patent_app_type] => utility [patent_app_number] => 18/654709 [patent_app_country] => US [patent_app_date] => 2024-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 5624 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18654709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19359266 [patent_doc_number] => 20240261300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-08-08 [patent_title] => METHODS OF TREATING CONGENITAL ADRENAL HYPERPLASIA [patent_app_type] => utility [patent_app_number] => 18/438060 [patent_app_country] => US [patent_app_date] => 2024-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19942 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18438060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19170791 [patent_doc_number] => 20240156765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => METHODS OF NEUROPROTECTION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/420262 [patent_app_country] => US [patent_app_date] => 2024-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29925 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -26 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18420262 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19521063 [patent_doc_number] => 12122770 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-10-22 [patent_title] => 2-(benzo[d]oxazol-2-yl)-n'-(nicotinoyloxy)acetimidamide as an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/397098 [patent_app_country] => US [patent_app_date] => 2023-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4043 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18397098 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19226663 [patent_doc_number] => 12006296 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-06-11 [patent_title] => 5-(4-methoxyphenyl)-1-hexyl-2-(4-nitrophenyl)-4-phenyl-1H-imidazoleas an antimicrobial compound [patent_app_type] => utility [patent_app_number] => 18/535770 [patent_app_country] => US [patent_app_date] => 2023-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4260 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18535770 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19172372 [patent_doc_number] => 20240158346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-16 [patent_title] => METHOD OF PREPARING IONIC FLUIDS [patent_app_type] => utility [patent_app_number] => 18/519337 [patent_app_country] => US [patent_app_date] => 2023-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5732 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18519337 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19651217 [patent_doc_number] => 12172985 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-12-24 [patent_title] => 6-(6-bromo-2-oxo-2H-chromen-3-yl)-4-(3-bromophenyl)-2-alkoxynicotinonitrile as antimicrobial compounds [patent_app_type] => utility [patent_app_number] => 18/378862 [patent_app_country] => US [patent_app_date] => 2023-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4202 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18378862 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19105754 [patent_doc_number] => 11958835 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2024-04-16 [patent_title] => 6-(6-bromo-2-oxo-2H-chromen-3-yl)-4-(4-chlorophenyl)-2-alkoxynicotinonitrile as antimicrobial agents [patent_app_type] => utility [patent_app_number] => 18/377953 [patent_app_country] => US [patent_app_date] => 2023-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4132 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18377953 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18893714 [patent_doc_number] => 20240009199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-11 [patent_title] => PEMETREXED FORMULATIONS [patent_app_type] => utility [patent_app_number] => 18/470952 [patent_app_country] => US [patent_app_date] => 2023-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9371 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18470952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18860056 [patent_doc_number] => 20230414490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-12-28 [patent_title] => FORMULATIONS FOR PARENTERAL DELIVERY OF COMPOUNDS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/244446 [patent_app_country] => US [patent_app_date] => 2023-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22514 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18244446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18921281 [patent_doc_number] => 20240024285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-01-25 [patent_title] => INDOMETHACIN PHARMACEUTICAL COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/221295 [patent_app_country] => US [patent_app_date] => 2023-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3760 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18221295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18690945 [patent_doc_number] => 20230321117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => USE OF GANAXOLONE IN TREATING AN EPILEPSY DISORDER [patent_app_type] => utility [patent_app_number] => 18/328996 [patent_app_country] => US [patent_app_date] => 2023-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10952 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18328996 [rel_patent_id] =>[rel_patent_doc_number] =>)